Cy3-UTP ÒÖÖÆ¼Á BMPO Leukotriene D4 Ó«¹âȾÁÏ DMAPP ¶¨ÖƺϳÉ
HEPESÖÐÎıðÃû£ºN-(2-ôÇÒÒ»ù)ßßàº-N'-2-ÒÒÍé»ÇËá | 4-ôÇÒÒ | N-2-ôÇÒÒ»ùßßàº-N'-2-ÒÒ»ÇËá(HEPES) | 4-(2-ôÇÒÒ»ù)-1-ßßົù]ÒÒ»ÇËá | N-2-ôÇÒÒ»ùßßàº-N'-2-ÒÒ»ÇËá | 4-(2-ôÇÒÒ»ù)-1-ßßàºÒÒ»ÇËá | ôÇÒÒ»ùßßàºÒÒ»ÇËá | N-(2-ôÇÒÒ»ù)ßßàº-N¡¯-2-ÒÒÍé»ÇËá
1¡¢4-ôÇÒÒ»ùßßàºÒÒ»ÇËáÎïÀí²ÎÊý£º
³£ÓÃÃû
4-ôÇÒÒ»ùßßàºÒÒ»ÇËá
Ó¢ÎÄÃû
HEPES
CASºÅ
7365-45-9
·Ö×ÓÁ¿
238.305
ÃܶÈ
1.3¡À0.1 g/cm3
·Ðµã
ÎÞ×ÊÁÏ
·Ö×Óʽ
C8H18N2O4S
ÈÛµã
234-238 ¡ãC
ÉÁµã
2¡¢4-ôÇÒÒ»ùßßàºÒÒ»ÇËáÓÃ;£º
HEPES ÊÇÒ»ÖÖÁ½ÐÔÀë×Ó»¯Ñ§»º³å¼Á£¬¹ã·ºÓ¦ÓÃÓÚϸ°ûÅàÑø¡£HEPES ÔÚ pH ֵΪ 6.8 ÖÁ 8.2 ʱΪÓÐЧµÄ»º³åÒº¡£HEPES ÊÇÈÜøÌåÉúÎï·¢ÉúµÄÓÐЧÓÕµ¼¼Á¡£
3¡¢4-ôÇÒÒ»ùßßàºÒÒ»ÇËáÎïÀí»¯Ñ§ÐÔÖÊ£º
ÃÜ·âÓÚ2-8?CÒõÁ¹¸ÉÔï»·¾³¡£
Èç¹û×ñÕÕ¹æ¸ñʹÓúʹ¢´æÔò²»»á·Ö½â¡£
1¡¢ Ħ¶ûÕÛÉäÂÊ£º56.69
2¡¢ Ħ¶ûÌå»ý£¨m3/mol£©£º179.7
3¡¢ µÈÕűÈÈÝ£¨90.2K£©£º487.2
4¡¢ ±íÃæÕÅÁ¦£¨dyne/cm£©£º53.9
5¡¢ ¼«»¯ÂÊ£¨10 -24cm 3£©£º22.47
1.ÊèË®²ÎÊý¼ÆËã²Î¿¼Öµ£¨XlogP£©:-4
2.Çâ¼ü¹©ÌåÊýÁ¿:2
3.Çâ¼üÊÜÌåÊýÁ¿:6
4.¿ÉÐýת»¯Ñ§¼üÊýÁ¿:5
5.»¥±äÒì¹¹ÌåÊýÁ¿:ÎÞ
6.ÍØÆË·Ö×Ó¼«ÐÔ±íÃæ»ý89.5
7.ÖØÔ×ÓÊýÁ¿:15
8.±íÃæµçºÉ:0
9.¸´ÔÓ¶È:267
10.Í¬Î»ËØÔ×ÓÊýÁ¿:0
11.È·¶¨Ô×ÓÁ¢¹¹ÖÐÐÄÊýÁ¿:0
12.²»È·¶¨Ô×ÓÁ¢¹¹ÖÐÐÄÊýÁ¿:0
13.È·¶¨»¯Ñ§¼üÁ¢¹¹ÖÐÐÄÊýÁ¿:0
14.²»È·¶¨»¯Ñ§¼üÁ¢¹¹ÖÐÐÄÊýÁ¿:0
15.¹²¼Û¼üµ¥ÔªÊýÁ¿:1
4¡¢4-ôÇÒÒ»ùßßàºÒÒ»ÇËáÉú̬ѧÊý¾Ý£º
¸ÃÎïÖʶԻ·¾³¿ÉÄÜÓÐΣº¦£¬¶ÔË®ÌåÓ¦¸øÓèÌØ±ð×¢Òâ¡£
5¡¢4-ôÇÒÒ»ùßßàºÒÒ»ÇËáÐÔÖÊÓëÎȶ¨ÐÔ£º
6¡¢4-ôÇÒÒ»ùßßàºÒÒ»ÇËáÖü´æ·½·¨£º
7¡¢Í¬Àà²úÆ·ÁÐ±í£º
Æ·ÅÆ
»õºÅ
ÖÐÎÄÃû³Æ
Ó¢ÎÄÃû³Æ
CAS
°ü×°
´¿¶È
MedBio
MED17466
Arginase inhibitor 1
1345808-25-4
2mg
¡Ý98%
MED17883
PF 1022A
133413-70-4
5mg
MED17820
BMS 195614
253310-42-8
50mg
MED17988
1,3-PBIT (dihydrobromide)
200716-66-1
100mg
MED17934
Ataciguat
254877-67-3
1mg
MED17715
Diethylmaleate
141-05-9
100ul
MED17898
1,4-DPCA
331830-20-7
25mg
MED17587
kb-NB77-78
1350622-33-1
10mg
MED17833
Deoxynivalenol
51481-10-8
500ug
MED17962
D-NMAPPD
35922-06-6
8¡¢4-ôÇÒÒ»ùßßàºÒÒ»ÇËáÎÄÏ×£º
Epigenetic reprogramming of the type III interferon response potentiates antiviral activity and suppresses tumor growth. PLoS Biol. 12(1) , e1001758, (2014)
Functional consequence of the MET-T1010I polymorphism in breast cancer. Oncotarget 6(5) , 2604-14, (2015)
Immunomodulation by the Pseudomonas syringae HopZ type III effector family in Arabidopsis. PLoS ONE 9(12) , e116152, (2014)
9¡¢4-ôÇÒÒ»ùßßàºÒÒ»ÇËáÓ¢ÎıðÃû£º
021-69568360
ÖÜÒ»ÖÁÖÜÎ壺8:30-17:30
¹ú¼Ò·¨¶¨½Ú¼ÙÈÕ³ýÍâ
±¾ÍøÕ¾ÏúÊÛµÄËùÓвúÆ·½öÓÃÓÚ¿ÆÑеȷÇÒ½ÁÆÓÃ;£¬·ÇÒ©Æ·²»¿ÉʳÓ㬲»¿ÉÓÃÓÚÈËÌå»ò¶¯ÎïµÄÁÙ´²Õï¶ÏºÍÖÎÁÆ¡£ÎÒÃDz»Îª¸öÈËÌṩ²úÆ·¼°·þÎñ¡£
Copyright © 2020-2025 MedBio All Rights Reserved ÉϺ£Âö²¬Ò½Ò©¿Æ¼¼ÓÐÏÞ¹«Ë¾
Ñϸñ½ûÖ¹ÔÚδ¾Í¬ÒâµÄÇé¿öÏÂ×ªÔØ±¾ÍøÕ¾Ö®ËùÓÐÐÅÏ¢¡£ÈçÐèÊÚȨ£¬ÇëÁªÏµÎÒ˾¡£
»¦¹«Íø°²±¸ 31011402010197ºÅ | | »¦ICP±¸2020034979ºÅ
MedBio¿Í·þ1
MedBio¿Í·þ2
MedBio¿Í·þ3
MedBio¿Í·þ4
MedBio¿Í·þ5
MedBio¿Í·þ6
400-186-1816